Heart disease in disorders of muscle, neuromuscular transmission, and nerve

다국어 초록 (Multilingual Abstract)

Little is known regarding cardiac involvement (CI) by neuromuscular disorders (NMDs). The purpose of this review is to summarise and discuss the major findings concerning the types, frequency, and severity of cardiac disorders in NMDs as well as their diagnosis, treatment, and overall outcome. CI in NMDs is characterized by pathologic involvement of the myocardium or cardiac conduction system. Less commonly, additional critical anatomic structures, such as the valves, coronary arteries, endocardium, pericardium, and even the aortic root may be involved. Involvement of the myocardium manifests most frequently as hypertrophic or dilated cardiomyopathy and less frequently as restrictive cardiomyopathy, non-compaction, arrhythmogenic right-ventricular dysplasia, or Takotsubo-syndrome. Cardiac conduction defects and supraventricular and ventricular arrhythmias are common cardiac manifestations of NMDs. Arrhythmias may evolve into life-threatening ventricular tachycardias, asystole, or even sudden cardiac death. CI is common and carries great prognostic significance on the outcome of dystrophinopathies, laminopathies, desminopathies, nemaline myopathy, myotonias, metabolic myopathies, Danon disease, and Barth-syndrome. The diagnosis and treatment of CI in NMDs follows established guidelines for the management of cardiac disease, but cardiotoxic medications should be avoided. CI in NMDs is relatively common and requires complete work-up following the establishment of a neurological diagnosis. Appropriate cardiac treatment significantly improves the overall long-term outcome of NMDs.

참고문헌 (Reference)

• 1 D’Arcy C, "X-linked recessive distal myopathy with hypertrophic cardiomyopathy caused by a novel mutation in the FHL1 gene" 30 : 1211-1217, 2015
• 2 Eminoglu TF, "Very long-chain acyl CoA dehydrogenase deficiency which was accepted as infanticide" 210 : e1-e3, 2011
• 3 Pambrun T, "Unmasked Brugada pattern by ajmaline challenge in patients with myotonic dystrophy type 1" 20 : 28-36, 2015
• 4 Moustafa S, "Unforeseen cardiac involvement in McArdle’s disease" 22 : 769-771, 2013
• 5 Schoser B, "Unclassified polysaccharidosis of the heart and skeletal muscle in siblings" 95 : 52-58, 2008
• 6 Klein CJ, "Ubiquitin ligase defect by DCAF8mutation causes HMSN2 with giant axons" 82 : 873-878, 2014
• 7 Naddaf E, "Two families with MYH7 distal myopathy associated with cardiomyopathy and core formations" 16 : 164-169, 2015
• 8 Finsterer J, "Treatment of dystrophin cardiomyopathies" 11 : 168-179, 2014
• 9 Carr AS, "Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy" 25 : 511-515, 2015
• 10 김희나, "Transient Complete Atrioventricular Block in a Preterm Neonate with Congenital Myotonic Dystrophy: Case Report" 대한의학회 29 (29): 879-883, 2014
• 11 Matsuda H, "Total intravenous anesthesia for a patient with Fukuyama congenital muscular dystrophy undergoing scoliosis surgery" 63 : 650-653, 2014
• 12 Brunklaus A, "The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy" 19 : 395-401, 2015
• 13 Prater SN, "The emerging phenotype of long-term survivors with infantile Pompe disease" 14 : 800-810, 2012
• 14 Gal A, "The coexistence of dynamin 2mutation and multiple mitochondrial DNA (mtDNA) deletions in the background of severe cardiomyopathy and centronuclear myopathy" 34 : 89-95, 2015
• 15 Massari FM, "Tako-tsubo syndrome in a young man with amyotrophic lateral sclerosis. A case report" 12 : 388-391, 2011
• 16 Finsterer J, "Syncope and hyperCKemia as minimal manifestations of short CTG repeat expansions in myotonic dystrophy type 1" 34 : 361.e1-361.e4, 2015
• 17 Wochna K, "Sudden death due to malignant hyperthermia during general anesthesia" 63 : 11-14, 2013
• 18 Miani D, "Sudden death associated with danon disease in women" 109 : 406-411, 2012
• 19 Plonka C, "Successful heart transplantation from a donor with Ullrich congenital muscular dystrophy" 13 : 1915-1917, 2013
• 20 Hollingsworth KG, "Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I" 15 : 986-994, 2013
• 21 Dec GW, "Steroid therapy effectively delays Duchenne’s cardiomyopathy" 61 : 955-956, 2013
• 22 Barisić N, "Spinal dysraphism associated with congenital heart disorder in a girl with MELAS syndrome and point mutation at mitochondrial DNA nucleotide 3271" 43 : 37-41, 2002
• 23 Mogahed EA, "Skeletal and cardiac muscle involvement in children with glycogen storage disease type III" 174 : 1545-1548, 2015
• 24 Piñol-Ripoll G, "Severe infantile-onset cardiomyopathy associated with a homozygous deletion in desmin" 19 : 418-422, 2009
• 25 Hikita T, "Severe infantile myotubular myopathy with complete atrioventricular block" 50 : 698-700, 2008
• 26 Lee TM, "Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9" 18 : 183-186, 2012
• 27 Ishiwata S, "Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles" 57 : 928-933, 1993
• 28 Pane M, "Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency" 22 : 685-689, 2012
• 29 Nishikawa A, "Respiratory and cardiac function in Japanese patients with dysferlinopathy" 2015
• 30 Stöllberger C, "Repeated radiofrequency ablation of atrial tachycardia in restrictive cardiomyopathy secondary to myofibrillar myopathy" 25 : 905-907, 2014
• 31 Hertzman PA, "Repeated coronary artery spasm in a young woman with the eosinophilia-myalgia syndrome" 267 : 2932-2934, 1992
• 32 Millaire A, "Refsum’s disease. Apropos of 2 cases disclosed by myocardiopathy" 39 : 173-178, 1990
• 33 Nakagawa H, "Refractory high output heart failure in a patient with primary mitochondrial respiratory chain disease" 53 : 315-319, 2014
• 34 Uechi Y, "Recurrent takotsubo cardiomyopathy within a short span of time in a patient with hereditary motor and sensory neuropathy" 47 : 1609-1613, 2008
• 35 Chauveau C, "Recessive TTN truncating mutations define novel forms of core myopathy with heart disease" 23 : 980-991, 2014
• 36 Rubin HJ, "Progressive muscular dystrophy with involvement of heart muscle" 4 : 141-156, 1947
• 37 Flöck A, "Progressive cardiac dysfunction in Bethlem myopathy during pregnancy" 123 (123): 436-438, 2014
• 38 Petri H, "Progression of cardiac involvement in patients with limb-girdle type 2 and Becker muscular dystrophies:a 9-year follow-up study" 182 : 403-411, 2015
• 39 Yilmaz BS, "Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up" 28 : 1179-1181, 2015
• 40 Volpi L, "Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNA gene duplication" 20 : 512-516, 2010
• 41 Limongelli G, "Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease" 12 : 114-121, 2010
• 42 LaBarbera M, "Premature coronary artery disease in a patient with glycogen storage disease III" 22 : E156-E158, 2010
• 43 Müller TJ, "Phenotype of matrin-3-related distal myopathy in 16 German patients" 76 : 669-680, 2014
• 44 Rakocević-Stojanović V, "Pathohistological changes in endomyocardial biopsy specimens in patients with myotonic dystrophy" 41 : 27-30, 1999
• 45 Russo V, "Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis" 19 : 1241-1248, 2015
• 46 Missaglia S, "Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings" 115 : 110-117, 2015
• 47 Martinez HR, "Novel cardiovascular findings in association with a POMT2mutation: three siblings with α-dystroglycanopathy" 22 : 486-491, 2014
• 48 Finsterer J, "Novel MYH7 mutation associated with mild myopathy but lifethreatening ventricular arrhythmias and noncompaction" 173 : 532-535, 2014
• 49 Finsterer J, "Noncompaction in myotonic dystrophy type 1 on cardiac MRI" 103 : 167-168, 2005
• 50 Oliveira J, "New splicing mutation in the choline kinase beta (CHKB) gene causing a muscular dystrophy detected by whole-exome sequencing" 60 : 305-312, 2015
• 51 Nalini A, "New mutation of the desmin gene identified in an extended Indian pedigree presenting with distal myopathy and cardiac disease" 61 : 622-626, 2013
• 52 Gatayama R, "Nemaline myopathy with dilated cardiomyopathy in childhood" 131 : e1986-e1990, 2013
• 53 Sarullo FM, "Nemaline myopathy and heart failure: role of ivabradine; a case report" 15 : 5-, 2015
• 54 Finsterer J, "Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy" 83 : 9-17, 2015
• 55 Liewluck T, "Myofibrillar myopathy with limb-girdle phenotype in a Thai patient" 92 : 290-295, 2009
• 56 Petri H, "Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study" 16 : 59-, 2014
• 57 Tandon A, "Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy" 4 : e001338-, 2015
• 58 Lang SM, "Myocardial fibrosis and left ventricular dysfunction in Duchenne muscular dystrophy carriers using cardiac magnetic resonance imaging" 36 : 1495-1501, 2015
• 59 Aimo A, "Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance" 176 : 1396-1398, 2014
• 60 Mayor-Gomez S, "Myasthenic crisis and Takotsubo syndrome: a non-chance relationship" 55 : 725-728, 2012
• 61 Tsubata S, "Mutations in the human deltasarcoglycan gene in familial and sporadic dilated cardiomyopathy" 106 : 655-662, 2000
• 62 Cullup T, "Mutations in MYH7 cause Multiminicore Disease (MmD) with variable cardiac involvement" 22 : 1096-1104, 2012
• 63 Kopajtich R, "Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy" 95 : 708-720, 2014
• 64 Wang SB, "Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy" 49 : 145-149, 2008
• 65 Kayman-Kurekci G, "Mutation in TOR1AIP1encoding LAP1B in a form of muscular dystrophy: a novel gene related to nuclear envelopathies" 24 : 624-633, 2014
• 66 Nishino I, "Molecular pathomechanism of distal myopathy with rimmed vacuoles" 45 : 943-945, 2005
• 67 Iacobazzi V, "Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency" 24 : 312-320, 2004
• 68 Dominic EA, "Mitochondrial cytopathies and cardiovascular disease" 100 : 611-618, 2014
• 69 Wortmann SB, "Mitochondrial DNA m.3242G > A mutation, an under diagnosed cause of hypertrophic cardiomyopathy and renal tubular dysfunction?" 55 : 552-556, 2012
• 70 Distelmaier F, "MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset hypertrophic cardiomyopathy" 16 : 319-323, 2015
• 71 Benhayon D, "Long-term arrhythmia follow-up of patients with myotonic dystrophy" 26 : 305-310, 2015
• 72 Brecht M, "Leigh syndrome daused by the MT-ND5 m.13513G>A mutation:a case present ing wi th WPW-l ike conduct ion defect , cardiomyopathy, hypertension and hyponatraemia" 19 : 95-100, 2015
• 73 Yoda M, "Left ventriculoplasty for dilated cardiomyopathy in Fukuyama-type muscular dystrophy" 40 : 514-516, 2011
• 74 Şimşek Z, "Left ventricular noncompaction in a patient with multiminicore disease" 13 : 660-662, 2012
• 75 Wahbi K, "Left ventricular non-compaction in a patient with myotonic dystrophy type 2" 18 : 331-333, 2008
• 76 Gossios TD, "Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1" 56 : 251-255, 2013
• 77 Corrado G, "Left ventricular hypertrabeculation/noncompaction with PMP22duplication-based Charcot-Marie-Tooth disease type 1A" 105 : 142-145, 2006
• 78 Finsterer J, "Left ventricular hypertrabeculation/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation" 60 : 445-448, 2005
• 79 Bu’Lock FA, "Left ventricular diastolic function in congenital myotonic dystrophy" 80 : 267-270, 1999
• 80 Van Der Starre P, "Late profound muscle weakness following heart transplantation due to Danon disease" 47 : 135-137, 2013
• 81 Maggi L, "LMNA-associated myopathies: the Italian experience in a large cohort of patients" 83 : 1634-1644, 2014
• 82 Fanin M, "LGMD2E patients risk developing dilated cardiomyopathy" 13 : 303-309, 2003
• 83 Barragán-Campos HM, "Kearns-Sayre syndromes an absolute indication for prophylactic implantation of definitive pacemaker?" 69 : 559-565, 1999
• 84 Finsterer J, "Is atherosclerosis a mitochondrial disorder?" 36 : 229-240, 2007
• 85 Ronvelia D, "Intrafamilial variability for novel TAZ gene mutation: barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle" 107 : 428-432, 2012
• 86 Josef Finsterer, "Intermittent Pre-Excitation-Syndrome in Facio-Scapulo-Humeral Muscular Dystrophy" 대한심장학회 44 (44): 348-350, 2014
• 87 Sakpichaisakul K, "Identification of Sandhoff disease in a Thai family: clinical and biochemical characterization" 93 : 1088-1092, 2010
• 88 Coutance G, "Hypoplasia of the aorta in a patient diagnosed with LMNA gene mutation" 8 : E127-E129, 2013
• 89 Mir A, "Hypertrophic cardiomyopathy in a neonate associated with nemaline myopathy" 7 : E37-E41, 2012
• 90 Palecek T, "Hypertrophic cardiomyopathy due to the mitochondrial DNA mutation m.3303C>T diagnosed in an adult male" 53 : 383-387, 2012
• 91 Merlini L, "Homogeneous phenotype of the gypsy limb-girdle MD with the gamma-sarcoglycan C283Y mutation" 54 : 1075-1079, 2000
• 92 Malfatti E, "High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation" 80 : 100-105, 2013
• 93 Petri H, "High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a crosssectional study" 174 : 31-36, 2014
• 94 Hachenberg T, "Heart transplantation in a patient with central core disease" 6 : 386-387, 1992
• 95 D’Amico A, "Heart transplantation in a child with LGMD2I presenting as isolated dilated cardiomyopathy" 18 : 153-155, 2008
• 96 Homan DJ, "Heart transplantation for a patient with Kearns-Sayre syndrome and end-stage heart failure" 17 : 102-104, 2011
• 97 Della Marca G, "Heart rate variability in facioscapulohumeral muscular dystrophy" 25 : 211-216, 2010
• 98 Sentner CP, "Heart failure due to severe hypertrophic cardiomyopathy reversed by low calorie, high protein dietary adjustments in a glycogen storage disease type IIIa patient" 5 : 13-16, 2012
• 99 Hofstad H, "Heart disease in myasthenia gravis" 70 : 176-184, 1984
• 100 Coelho E, "Heart changes in the familial type of paramyloidosis with peripheral neuropathy" 52 : 1066-1078, 1963
• 101 Magoulas PL, "Glycogen Storage Disease Type IV. 2013Jan 03. GeneReviews®" University of Washington
• 102 Ojala T, "Fetal left ventricular noncompaction cardiomyopathy and fatal outcome due to complete deficiency of mitochondrial trifunctional protein" 174 : 1689-1692, 2015
• 103 Amit R, "Fatal familial infantile glycogen storage disease: multisystem phosphofructokinase deficiency" 15 : 455-458, 1992
• 104 Calvo F, "Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients" 10 : 560-566, 2000
• 105 Quick S, "Evaluation of heart involvement in calpainopathy (LGMD2A) using cardiovascular magnetic resonance" 52 : 661-663, 2015
• 106 But WM, "Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation" 15 : 474-477, 2009
• 107 Beydoun SR, "Emotional stress as a trigger of myasthenic crisis and concomitant takotsubo cardiomyopathy: a case report" 4 : 393-, 2010
• 108 Tsuda T, "Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27" 60 : 151-155, 2015
• 109 Brisca G, "Early onset cardiomyopathy associated with the mitochondrial tRNALeu((UUR)) 3271T>C MELAS mutation" 458 : 601-604, 2015
• 110 Tiffin HR, "Dysregulation of FHL1spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype" 14 : 113-121, 2013
• 111 Krendel DA, "Distal vacuolar myopathy with complete heart block" 45 : 698-699, 1988
• 112 Kimpara T, "Distal myopathy with rimmed vacuoles and sudden death--report of two siblings" 33 : 886-890, 1993
• 113 Brunetti-Pierri N, "Dilation of the aortic root in mitochondrial disease patients" 103 : 167-170, 2011
• 114 Finsterer J, "Dilated, arrhythmogenic cardiomyopathy in emery-dreifuss muscular dystrophy due to the emerin splice-site mutation c.449 + 1G>A" 130 : 48-51, 2015
• 115 Carboni N, "Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype?" 44 : 826-828, 2011
• 116 Yasuma F, "Dilated cardiomyopathy in Kugelberg-Welander disease: coexisting sleep disordered breathing and its treatment with continuous positive airway pressure" 43 : 951-954, 2004
• 117 Schottlaender LV, "Diagnostic clues and manifesting carriers in fukutin-related protein (FKRP) limbgirdle muscular dystrophy" 348 : 266-268, 2015
• 118 van Westering TL, "Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy" 20 : 8823-8855, 2015
• 119 Pasqualin LM, "Congenital muscular dystrophy with dropped head linked to the LMNA gene in a Brazilian cohort" 50 : 400-406, 2014
• 120 Kajino S, "Congenital fiber type disproportion myopathy caused by LMNA mutations" 340 : 94-98, 2014
• 121 Vattemi G, "Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy" 30 : 121-126, 2011
• 122 Zhang RN, "Clinical features and mutations in seven Chinese patients with very long chain acyl-CoA dehydrogenase deficiency" 10 : 119-125, 2014
• 123 Takahashi T, "Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B" 84 : 433-440, 2013
• 124 Haliloglu G, "Clinical characteristics of megaconial congenital muscular dystrophy due to choline kinase beta gene defects in a series of 15 patients" 38 : 1099-1108, 2015
• 125 van den Bergen JC, "Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy" 85 : 92-98, 2014
• 126 El-Menyar AA, "Clinical and histologic studies of a Qatari family with myofibrillar myopathy" 25 : 1723-1726, 2004
• 127 Semplicini C, "Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E" 84 : 1772-1781, 2015
• 128 Baruteau J, "Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients" 36 : 795-803, 2013
• 129 Losito L, "Charcot-Marie-Tooth type 1a in a child with Long QT syndrome" 13 : 459-462, 2009
• 130 Florian A, "Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy" 17 : 40-, 2015
• 131 Al-Ruwaishid A, "Centronuclear myopathy and cardiomyopathy requiring heart transplant" 25 : 62-66, 2003
• 132 Watanabe Y, "Case of Leber’s hereditary optic neuropathy with mitochondrial DNA 11778 mutation exhibiting cerebellar ataxia, dilated cardiomyopathy and peripheral neuropathy" 61 : 309-312, 2009
• 133 Rosales XQ, "Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I" 13 : 39-, 2011
• 134 Jefferies JL, "Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: results from the pediatric cardiomyopathy registry" 21 : 877-884, 2015
• 135 Gdynia HJ, "Cardiomyopathy in motor neuron diseases" 77 : 671-673, 2006
• 136 Dittrich S, "Cardiomyopathy in duchenne muscular dystrophy: current value of clinical, electrophysiological and imaging findings in children and teenagers" 227 : 225-231, 2015
• 137 Redondo-Vergé, "Cardioembolic stroke prompting diagnosis of LMNAassociated Emery-Dreifuss muscular dystrophy" 44 : 587-589, 2011
• 138 Zheng M, "Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death" 18 : 701-713, 2009
• 139 Tanaka Y, "Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: analysis using cardiac [123I] MIBG scintigraphy" 260 : 2380-2386, 2013
• 140 Andrikopoulos G, "Cardiac resynchronization therapy in becker muscular dystrophy" 54 : 227-229, 2013
• 141 Kilic T, "Cardiac resynchronization therapy in a case of myotonic dystrophy (Steinert’s disease) and dilated cardiomyopathy" 30 : 916-920, 2007
• 142 Birnkrant DJ, "Cardiac phenotype determines survival in Duchenne muscular dystrophy" 2015
• 143 Austin SL, "Cardiac pathology in glycogen storage disease type III" 6 : 65-72, 2012
• 144 Palladino A, "Cardiac involvement in patients with spinal muscular atrophies" 30 : 175-178, 2011
• 145 Sveen ML, "Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy" 65 : 1196-1201, 2008
• 146 Gaul C, "Cardiac involvement in limb-girdle muscular dystrophy 2I: conventional cardiac diagnostic and cardiovascular magnetic resonance" 253 : 1317-1322, 2006
• 147 Florian A, "Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study" 2015
• 148 Faustmann PM, "Cardiac involvement in facio-scapulo-humeral muscular dystrophy:a family study using Thallium-201 single-photon-emissioncomputed tomography" 144 : 59-63, 1996
• 149 Elkohen M, "Cardiac involvement in Kugelberg-Welander disease. A prospective study of 8 cases" 89 : 611-617, 1996
• 150 Wessely R, "Cardiac involvement in Emery-Dreifuss muscular dystrophy" 67 : 220-223, 2005
• 151 Schade van Westrum SM, "Cardiac involvement in Dutch patients with sarcoglycanopathy: a crosssectional cohort and follow-up study" 50 : 909-913, 2014
• 152 Vidal-Pérez R, "Cardiac involvement in Becker muscular dystrophy: role of cardiovascular magnetic resonance" 14 : 1038-, 2013
• 153 Namazi MH, "Cardiac failure as an unusual presentation in a patient with history of amyotrophic lateral sclerosis" 2014 : 986139-, 2014
• 154 Nakayama T, "Cardiac deformity and dysfunction in facioscapulohumeral dystrophy--electrocardiogram, ECG gate cardiac MRI studies" 39 : 610-614, 1999
• 155 Wahbi K, "Cardiac assessment of limbgirdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study" 18 : 650-655, 2008
• 156 Stunnenberg BC, "Cardiac arrhythmias in hypokalemic periodic paralysis: Hypokalemia as only cause?" 50 : 327-332, 2014
• 157 Ergül Y, "Cardiac arrest after anesthetic management in a patient with hereditary sensory autonomic neuropathy type IV" 5 : 93-95, 2011
• 158 Brea-Calvo G, "COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10deficiency" 96 : 309-317, 2015
• 159 Rudnik-Schöneborn S, "Brugada-like cardiac disease in myotonic dystrophy type 2: report of two unrelated patients" 18 : 191-194, 2011
• 160 Araki A, "Brugada syndrome in spinal and bulbar muscular atrophy" 82 : 1813-1821, 2014
• 161 Bansal V, "Broken heart syndrome in myasthenia gravis" 44 : 990-993, 2011
• 162 Thanaviratananich S, "Broken heart syndrome during myasthenic crisis" 15 : 90-95, 2014
• 163 Caballero PE, "Becker myotonia congenita associated with Wolff-Parkinson-White syndrome" 17 : 38-40, 2011
• 164 Nussinovitch U, "Beat-tobeat QT interval dynamics and variability in familial dysautonomia" 31 : 80-84, 2010
• 165 Lee HC, "BAG3-related myofibrillar myopathy in a Chinese family" 81 : 394-398, 2012
• 166 Konersman CG, "BAG3 myofibrillar myopathy presenting with cardiomyopathy" 25 : 418-422, 2015
• 167 Shemisa K, "Autonomic etiology of heart block in amyotrophic lateral sclerosis: a case report" 8 : 224-, 2014
• 168 Marques J, "Atypical phenotype in two patients with LAMA2 mutations" 24 : 419-424, 2014
• 169 Maffè S, "Atypical arrhythmic complications in familial hypokalemic periodic paralysis" 10 : 68-71, 2009
• 170 Sacconi S, "Atrio-ventricular block requiring pacemaker in patients with late onset Pompe disease" 24 : 648-650, 2014
• 171 Brembilla-Perrot B, "Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy" 37 : 329-335, 2014
• 172 Longhi S, "Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role" 22 : 147-155, 2015
• 173 Ceviz N, "Assessment of left ventricular systolic and diastolic functions in children with merosin-positive congenital muscular dystrophy" 87 : 129-133, 2003
• 174 Groh WJ, "Arrhythmias in the muscular dystrophies" 9 : 1890-1895, 2012
• 175 Finsterer J, "Apical ballooning (Takotsubo syndrome) in mitochondrial disorder during mechanical ventilation" 8 : 859-863, 2007
• 176 Fujita K, "An adult case of congenital fiber type disproportion (CFTD) with cardiomyopathy" 45 : 380-382, 2005
• 177 Viitasalo MT, "Ambulatory electrocardiographic recording in mild or moderate myotonic dystrophy and myotonia congenita (Thomsen’s disease)" 62 : 181-190, 1983
• 178 Al-Thihli K, "A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy" 497 : 320-322, 2012
• 179 Green DS, "A proposed mutation, Val781Ile, associated with hyperkalemic periodic paralysis and cardiac dysrhythmia is a benign polymorphism" 42 : 253-256, 1997
• 180 Kuru S, "A patient with limb girdle muscular dystrophy type 2B (LGMD2B) manifesting cardiomyopathy" 44 : 375-378, 2004
• 181 Hattori T, "A patient with Kennedy-Alter-Sung syndrome showing cardiomyopathy" 35 : 1246-1249, 1995
• 182 Pen AE, "A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology" 58 : 222-229, 2015
• 183 Kaneko K, "A novel mutation in PNPLA2causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review" 24 : 634-641, 2014
• 184 Menotti F, "A novel mtDNA point mutation in tRNA(Val) is associated with hypertrophic cardiomyopathy and MELAS" 5 : 460-465, 2004
• 185 Iwahara N, "A novel lamin A/C gene mutation causing spinal muscular atrophy phenotype with cardiac involvement: report of one case" 15 : 13-, 2015
• 186 Guo X, "A novel dystrophin deletion mutation in a becker muscular dystrophy patient with early-onset dilated cardiomyopathy" 30 : 956.e1-956.e3, 2014
• 187 Lefter S, "A novel MYH7 Leu1453pro mutation resulting in Laing distal myopathy in an Irish family" 25 : 155-160, 2015
• 188 Dinçer P, "A homozygous nonsense mutation in delta-sarcoglycan exon 3 in a case of LGMD2F" 10 : 247-250, 2000
• 189 Tanahashi N, "A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis" 53 : 30-42, 2004
• 190 Yajima N, "A case of mitochondrial cardiomyopathy with pericardial effusion evaluated by (99m)Tc-MIBI myocardial scintigraphy" 16 : 989-994, 2009
• 191 Matsui M, "A case of limbgirdle muscular dystrophy 2M diagnosed by the occurence of dilated cardiomyopathy" 55 : 585-588, 2015
• 192 Okere A, "A cardiomyopathy in a patient with limb girdle muscular dystrophy type 2A" 6 : e12-e13, 2013
• 193 Authors/Task Force members, "2014ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)" 35 : 2733-2779, 2014